Clinical utility of sarcoma methylation classifiers in soft tissue sarcoma diagnosis
Soft tissue sarcomas are rare malignant tumors of mesenchymal origin characterized by their heterogeneity and diagnosis is challenging despite integrated histopathology and molecular testing. DNA methylation profiling offers an objective approach for tumor classification, but clinical implementation...
Salvato in:
| Autori principali: | , , , , , , , , , , , , |
|---|---|
| Natura: | Article (Journal) |
| Lingua: | inglese |
| Pubblicazione: |
6 May 2026
|
| In: |
Journal of cancer research and clinical oncology
Year: 2026, Volume: 152, Fascicolo: 5, Pages: 1-9 |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-026-06494-w |
| Accesso online: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00432-026-06494-w |
| Note sull'autore: | Justus Osterloh, David E. Reuss, Andreas von Deimling, Hannah Füllgraf, Jannis Heyer, Konrad Kurowski, Clara Kirchhof, Anna Meiertoberens, Ute Lausch, Adrian Schmid, Steffen U. Eisenhardt, David Braig, Alexander Runkel |
| Riassunto: | Soft tissue sarcomas are rare malignant tumors of mesenchymal origin characterized by their heterogeneity and diagnosis is challenging despite integrated histopathology and molecular testing. DNA methylation profiling offers an objective approach for tumor classification, but clinical implementation data in soft tissue sarcoma remain limited. |
|---|---|
| Descrizione del documento: | Gesehen am 15.09.2026 |
| Descrizione fisica: | Online Resource |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-026-06494-w |